We are all well aware that COVID-19 has been a major impetus for change in the world and not least in the healthcare market research/BI industry. The future of market research in our industry is evolving and changing due to the pandemic in particular, so it’s a great time to take stock and see where the industry is heading over the next few years.
EphMRA is running a panel discussion on 11 May which will comprise of panellists from industry.
Yvonne Engler, VP, Head of Customer & Business Insights CV/WHC/Pulm core and pipeline brands, Bayer Pharma AG
Karsten Trautmann, EphMRA President & Head of GSI Center of Excellence, Merck Healthcare KGaA
Artur Pieniadz, Director, EU Cluster Market Research, Business Insights and Analytics, Bristol Myers Squibb
4th panellist to be announced soon
This panel discussion will be facilitated by Letizia Leprini, Customer Business Insights, Bayer Pharmaceutical Division. Letizia is a long standing member of the EphMRA Conference Programme Steering Committee and also one of the convenors of the EphMRA Switzerland meeting, which will take place in September online.
Please join us for this interactive event. You will have an opportunity to not only listen to colleagues at the forefront of industry but to participate in asking questions.
You can register for this free event using the Zoom link below: